King K A, Pang C C
Br J Pharmacol. 1987 Mar;90(3):531-6. doi: 10.1111/j.1476-5381.1987.tb11202.x.
The effects of injections of arginine vasopressin (AVP) into the nucleus tractus solitarius (NTS) on mean arterial pressure (MAP), heart rate (HR) and plasma concentrations of noradrenaline and adrenaline were investigated in conscious, unrestrained rats. Injection of 2 ng AVP into the NTS significantly increased MAP but not plasma catecholamine concentrations, while injection of 10 ng AVP significantly increased MAP and plasma noradrenaline and adrenaline levels. Neither dose of AVP produced any change in HR. The vehicle did not affect MAP, HR or plasma catecholamine levels. Injection of a specific pressor antagonist of AVP, d(CH2)5Tyr-(Me)AVP (10 ng), did not change MAP, HR or plasma noradrenaline or adrenaline levels. These results suggest that the NTS is a central site of the pressor action of AVP. However, since the injection of the AVP antagonist did not reduce MAP or plasma noradrenaline or adrenaline levels, it suggests that AVP does not act tonically at the NTS to influence sympathoadrenal outflow.
在清醒、不受束缚的大鼠中,研究了向孤束核(NTS)注射精氨酸加压素(AVP)对平均动脉压(MAP)、心率(HR)以及去甲肾上腺素和肾上腺素血浆浓度的影响。向NTS注射2 ng AVP可显著升高MAP,但不影响血浆儿茶酚胺浓度;而注射10 ng AVP则可显著升高MAP以及血浆去甲肾上腺素和肾上腺素水平。两种剂量的AVP均未引起HR的任何变化。溶剂对照未影响MAP、HR或血浆儿茶酚胺水平。注射AVP的特异性升压拮抗剂d(CH2)5Tyr-(Me)AVP(10 ng),未改变MAP、HR或血浆去甲肾上腺素及肾上腺素水平。这些结果表明,NTS是AVP升压作用的一个中枢位点。然而,由于注射AVP拮抗剂并未降低MAP或血浆去甲肾上腺素及肾上腺素水平,这表明AVP并非通过持续作用于NTS来影响交感肾上腺系统的传出。